S-(-)-2,2'-Bis(diphenylphosphino)-1,1'-binaphthalene, 97.0%, 25g

3-Methyl-4,5-dihydro-1H-benzo[d]azepin-2(3H)-one, 98%, 100mg

Ethyl 1H-pyrrolo[3,2-c]pyridine-2-carboxylate, 95.0%, 25g

(2R,4R)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid, 98%, 250mg

2-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 96.0%, 100g

5-Methylisoxazole-4-carboxylic acid, 97.0%, 10g

Ethyl but-3-enoate (contains <30ppm MEHQ as inhibitor), 88.0%, 5g

Ethyl 5-acetamido-3-methylbenzofuran-2-carboxylate, 95%, 1g

3-Bromobenzenesulfonyl Chloride>98.0%(GC)(T)1g

2-(Chloromethyl)imidazo[1,2-a]pyridine, 95.0%, 100mg

Benzyltriethoxysilane>96.0%(GC)25g

{1-[2-(methylsulfanyl)phenyl]-1H-1,2,3-triazol-4-yl}methanol, 95.0%, 250mg

1-(2-bromophenyl)-2,5-dimethyl-1H-pyrrole-3-carbaldehyde, 95.0%, 1g